Last reviewed · How we verify
NCT06122272
An Exploratory Trial in Hong Kong to Explore the Effect of a New Formula
NA trial testing Test Formula in Healthy Subjects in 180 participants. Completed in 30 May 2025.
30 May 2025
Quick facts
| Lead sponsor | Danone Nutricia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 180 |
| Start date | 19 December 2023 |
| Primary completion | 30 May 2025 |
| Estimated completion | 30 May 2025 |
| Sites | 2 locations across China, Hong Kong |
Drugs / interventions tested
- Test Formula
- Control Formula
Conditions studied
- Healthy Subjects — all drugs for Healthy Subjects →
Sponsor
Danone Nutricia
Who can join
Adults 6 Months to 6 Months, any sex, with Healthy Subjects. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an exploratory study with the aim to gain insight and potentially generate hypotheses on health benefits of feeding with study product. This study explores in healthy subjects the effect of feeding with the test product compared to the control product in early life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06122272
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy Subjects
Currently open trials in the same condition.
- NCT07222020 — Phase 1 Study of Intravaginal KB15A · Phase 1 · recruiting
- NCT07350538 — The Critical Link Between Gut Microbiome Dysfunction, Cravings and Relapse: RECLAIM-GUT TRIAL · NA · active not recruiting
- NCT07304791 — This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics (PK), and P · Phase 1 · recruiting
- NCT07059858 — Bladder and Bowel Functions, Participation and Quality of Life in Children With Intellectual Disabilities · recruiting
- NCT07331389 — A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin · Phase 1 · recruiting
Other Danone Nutricia trials
Trials by the same sponsor.
- NCT06646458 — A Explorative Pilot Study to Gain Insights for a New Senior Milk Powder · NA · completed
- NCT06287385 — An Exploratory RWE Study Exploring Effects of a Goat Milk Based Young Child Formula on Health Benefits · NA · completed
- NCT05815147 — An Exploratory Real-world Study to Explore the Effects of Fortified Powdered Beverage on Sleep Quality in Chinese Adults · NA · completed
- NCT05235412 — A Cohort Study on Milk Composition, Health Outcomes, and Feeding Practices of Chinese Mothers and Infants · completed
- NCT04864665 — Study to Evaluate the Effects of a Formula on the Gut Health of Healthy Chinese Infants and Young Children · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06122272 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Danone Nutricia
- Last refreshed: 5 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06122272.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing